Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Liu J
Vaccination has been a cornerstone of modern medicine, substantially reducing the burden of infectious diseases worldwide. Traditional vaccine administration primarily targets systemic immunity through intramuscular or subcutaneous injection, overlooking the vast mucosal surfaces as critical sites of pathogen entry. This abstract delves into the evolving landscape of mucosal immunization strategies, exploring their potential to revolutionize vaccine development and delivery. Mucosal surfaces, including the respiratory, gastrointestinal, and genital tracts, represent the first line of defense against invading pathogens. Harnessing the power of mucosal immunity offers several advantages, including enhanced protection at mucosal entry sites, potential needle-free vaccine delivery, and broader cross-protection against related pathogens. This abstract discusses various mucosal immunization approaches, such as intranasal, oral, and intravaginal vaccination, highlighting their unique challenges and opportunities. Moreover, this abstract explores the current state of mucosal vaccine research and development, showcasing promising candidates targeting diseases like influenza, HIV, and SARS-CoV-2. It also addresses critical considerations, including safety, efficacy, and regulatory pathways, to ensure the successful translation of mucosal immunization strategies from the lab to the clinic.